HK Stock Market Move | CHINARES PHARMA (03320) fell more than 5% in early trading. Multiple companies under its umbrella announced their first quarter performance. KPC Pharmaceuticals, Inc. reported its first quarterly loss for the first time.

CHINARES PHARMA (03320) fell over 5% in early trading. As of the time of writing, it dropped by 5.54% to HKD 54.6 with a turnover of HKD 89.606 million. On the news front, several pharmaceutical companies under CHINARES PHARMA released their first-quarter results. China Resources Sanjiu Medical & Pharmaceutical saw a 15.29% year-on-year decline in net profit attributable to the parent company in the first quarter. Tasly Pharmaceutical Group's net profit attributable to the parent company in the first quarter was CNY 3.7 billion, with a year-on-year increase of 17.8%. Dong-E-E-Jiao achieved a net profit of CNY 4.55 billion in the first quarter, with a year-on-year growth of 7.14%. KPC Pharmaceuticals, Inc. recorded a revenue of CNY 836 million in the first quarter, a significant year-on-year decline of 48.01%, falling to a level not seen in the past ten years. The net profit attributable to the parent company incurred a loss of CNY 142 million, marking the first quarterly loss in twenty years.